Finance Minister Arun Jaitley on Tuesday underwent a planned diabetes management surgery at a private hospital in Delhi and was recovering well. Jaitley, 61, was admitted to the hospital in Saket......
Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits. Photograph: Tom Little/File......
The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent. IMAGE: Pens for the diabetes drug......
'Everyone with low BMI will not get Type 5 diabetes.' Kindly note the image has been posted only for representational purposes. Photograph: Kind courtesy Nataliya Vaitkevich/Pexels.com A recent......
Ahead of his homecoming, Group Captain Shubhanshu Shukla enjoyed a feast aboard the International Space Station. Photographs: Courtesy @JonnyKimUSA/X In the newly released images, Shukla and his......
Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the......
'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.' IMAGE: A pharmacist......
India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.......
The US Food and Drug Administration’s (USFDA)’s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars — lower-priced, near-replicas of complex biologic......
Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of the human insulin pen market by the end of this year and creates an......